ArticleACS omega2023

Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy.

Burak Erdönmez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.